Track the PharmaCorp Rx Inc. stock price and the full management transaction log of the company, a listed equity based in Canada. Shares are quoted on CA CA, under the supervision of SEDI. The latest transaction was disclosed on 15 July 2026 (15 - Acquisition or disposition under a prospectus). Among the most active insiders: Dumont, James. The full history is openly available.
10
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
18Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 23,265 of 27,989 companies
28.3
score / 100
Value
33
Quality
24
FCF yld-0.2%
Earn yld-1.4%
EV/EBITDA·
ROE-3.7%
Gross mgn40%
Net mgn-6.8%
Debt/EBITDA22.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
34,706 shares@ CA$0.5131.5% of flowCommon SharesTSXSEDI:4752520
Canonical exit: 7 Oct 2026 (T+90)
10 of 10 declarations
About PharmaCorp Rx Inc.
PharmaCorp Rx Inc. is a company focused on the development and commercialization of pharmaceuticals. It is listed on the Toronto Stock Exchange (XTSE).